Mrs. Travea D Cutts, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 106 Dostak Dr, Anderson, SC 29621 Phone: 864-226-2477 Fax: 864-226-2477 |
Mrs. Pauline C Thomason, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1221 Harriett Cir, Anderson, SC 29621 Phone: 864-716-3800 |
Carol Janine-gross Heaton, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1820 Highway 29 S, Anderson, SC 29626 Phone: 864-260-5215 |
Electric City Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2802 E North Ave, Anderson, SC 29625 Phone: 864-305-1982 Fax: 864-428-9802 |
Mrs. Suzanne C Humphreys, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 736 Marshall Ave, Anderson, SC 29621 Phone: 864-934-1147 |
Mrs. Margaret Bloomer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1501 E Greenville St, Anderson, SC 29621 Phone: 864-226-8356 |
Ms. Anna Shealy Gray, MSP/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Calrossie Rd, Anderson, SC 29621 Phone: 864-260-5105 |
Stephanie Draper Huie, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 311 Simpson Rd, Anderson, SC 29621 Phone: 864-261-3875 |
Regina Stallings Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 825 Allison Cir, Anderson, SC 29625 Phone: 803-270-9798 |
Anmed Ent - Voice Clinic Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1655 E Greenville St, Anderson, SC 29621 Phone: 864-512-2830 |
Danielle C. Smith, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-1417 Fax: 864-512-1823 |
News Archive
SeraCare Life Sciences, Inc. today announced that the Company has been awarded two new contracts from the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) and that a third existing contract has been expanded by the NIH to support federally-funded HIV research and testing. These contracts represent a combined $10.8 million in new funding if all options are exercised over the life of the contracts.
A trained scent dog accurately identified whether patients' urine samples had thyroid cancer or were benign (noncancerous) 88.2 percent of the time, according to a new study, to- be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
In this interview, we speak to Dr. Joshua E. Rosen about his latest research into treatment options and what role a surgeon's language plays in people's perception of its risks.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced today that it has made significant progress with its proprietary Cobalamin-targeted drug-delivery program for siRNA therapies.
› Verified 8 days ago